The highest number of cases, 75, were reported from Jaipur
The Arvind Kejriwal government took the decision after the Covid-19 positivity rate in the capital rose to 0.55 per cent on Sunday and 0.68 per cent on Monday
3,224 samples were examined for Covid-19 on Tuesday
Delhi sees 50% jump in cases from yesterday, while Mumbai reports nearly 70% rise
The Delhi Disaster Management Authority (DDMA) on Tuesday ordered the closure of schools, colleges, cinemas and gyms with immediate effect
The agenda of the meeting is to review the Covid-19 situation in Delhi and discuss preparations in the wake of rising Omicron cases
Of the seven cases, four were detected in Pathanamthitta, two in Alappuzha and one in Thiruvananthapuram
As many as 60,597 samples were tested in the last 24 hours
The Election Commission is likely to announce the dates of assembly elections for Uttar Pradesh, Uttarakhand, Goa, Punjab and Manipur early next month
The CDSCO has granted restricted emergency use authorisation to two new vaccines and a drug for Covid-19, taking to 12 the number of preventives and treatments available in India
A team of international researchers have shown that SARS-CoV-2, virus causing Covid-19, infects the kidneys and contributes to tissue scarring, possibly impacting kidney outcomes in the long term.
Homegrown pharma majors Sun Pharma, Cipla, Hetero, Torrent announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with Covid across India shortly.
Hetero said it has received permission from DCGI for manufacturing and marketing Molnupiravir capsules of 200 mg strength that is used to treat high-risk Covid adult patients.
Spas, gyms, yoga institutes and entertainment parks will remain closed, but outdoor yoga will be allowed
Night curfew will be imposed from 10 pm to 5 am; Delhi Metro, restaurants, bars to operate at 50% capacity
People aged 60 years and above with co-morbidities, who have received two doses of Covid vaccine, will on doctor's advice be provided with the precaution dose from Jan 10
Corbevax has completed two Phase III clinical trials involving more than 3000 subjects between the ages of 18 and 80 at 33 study sites across India
The DCGI has approved molnupiravir for treatment of adult patients with Covid and who have high risk of progression of the disease including hospitalisation or death
A new study led by an international team of researchers from South Africa, the US and Germany has now shown that the vaccine evading Omicron enhances neutralising immunity of the Delta variant
Russia was the first country to approve a Covid-19 vaccine for use in August 2020, developing their Sputnik V jab